Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s share price was down 3.8% during trading on Wednesday. The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares were traded during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The business has a 50 day moving average of C$0.26 and a 200 day moving average of C$0.26. The company has a market cap of C$52.28 million and a PE ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.
See Also
- Five stocks we like better than Emerald Health Therapeutics
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
